Valganciclovir is an effective prophylaxis for cytomegalovirus disease in liver transplant recipients

OBJECTIVES: Cytomegalovirus (CMV) infection is responsible for significant morbidity and mortality among solid organ transplant recipients. Prophylaxis using valganciclovir (VGCV) in orthotopic liver transplant (OLT) recipients is not approved by the Food and Drug Administration and its use is contr...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Main Authors: Fayek, Sameh Adel, Mantipisitkul, Wana, Rasetto, Flavia, Munivenkatappa, Raghava, Barth, Rolf N, Philosophe, Benjamin
Formato: Artigo
Idioma:Inglês
Publicado em: Blackwell Publishing Ltd 2010
Assuntos:
Original Articles
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC3003475/
https://ncbi.nlm.nih.gov/pubmed/21083790
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/j.1477-2574.2010.00226.x
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados